Pharma Capital
Showing 40 of 953
Name Market Market Cap Share Price Daily Share Movement
1300 SMILES LIMITED ASX £83.21m £3.91 0.16% ico_glass.png
1ST DENTAL LABS PRIVATE £- £- - ico_glass.png
4D Pharma AIM £235.29m £3.59 5.66% ico_glass.png
Abbvie NYSE £105,550.00m £66.21 0.00% ico_glass.png
Abeona Therapeutics NASDAQ £- £- - ico_glass.png
ABIOMED NASDAQ £- £- - ico_glass.png
abzena-logo.png Abzena plc AIM £70.50m £0.33 -2.94% ico_glass.png
AC Immune Ltd NASDAQ £- £- - ico_glass.png
Acceleron Pharma Inc NASDAQ £- £- - ico_glass.png
Accelrys NASDAQ £- £- - ico_glass.png
Accurexa OTCBB £- £- - ico_glass.png
AcelRx Pharmaceuticals NASDAQ £- £- - ico_glass.png
Acer Therapeutics PRIVATE £- £- - ico_glass.png
Achaogen NASDAQ £- £- - ico_glass.png
Achillion Pharmaceuticals NASDAQ £- £- - ico_glass.png
Acrux ASX £15.63m £0.09 0.00% ico_glass.png
Actinogen Medical Ltd ASX £21.78m £0.04 5.45% ico_glass.png
Adherium ASX £10.09m £0.06 -3.00% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £40.11m £0.16 1.96% ico_glass.png
Advanced Medical Solutions Group AIM £606.13m £2.86 0.00% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £16.19m £0.20 0.00% ico_glass.png
Advantis Corporation OTC £- £- - ico_glass.png
Aequus Pharmaceuticals Inc TSX-V £8.86m £0.12 8.11% ico_glass.png
Aethlon Medical Inc NASDAQ £- £- - ico_glass.png
Aetna NYSE £38,587.70m £116.19 -1.06% ico_glass.png
Affymax NASDAQ £- £- - ico_glass.png
AFP Imaging OTCMKTS £- £- - ico_glass.png
Agenix Limited ASX £- £- - ico_glass.png
Agenus NASDAQ £- £- - ico_glass.png
Agility Health TSX-V £3.29m £0.02 0.00% ico_glass.png
Agios Pharmaceuticals NASDAQ £- £- - ico_glass.png
AGTC NASDAQ £- £- - ico_glass.png
Ainsworth Lumber TSX £- £- 0.00% ico_glass.png
AirXpanders ASX £48.19m £0.50 8.50% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £5.78m £0.75 0.00% ico_glass.png
Akorn NASDAQ £- £- - ico_glass.png
Alchemia ASX £1.57m £0.00 0.00% ico_glass.png
Alcidion Group ASX £18.77m £0.03 -1.92% ico_glass.png
Alda Pharmaceuticals TSX-V £- £- - ico_glass.png
ALEGRO HEALTH CORP TSX-V £1.19m £0.02 25.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.